West completes Mulhuddart expansion citing insulin as driver

By Gareth Macdonald

- Last updated on GMT

West facility in Mulhuddart, Ireland (source Google maps)
West facility in Mulhuddart, Ireland (source Google maps)

Related tags Diabetes mellitus

Delivery device with West Pharmaceutical Services has completed the expansion of its plant in Mulhuddart, County Dublin.

West said the expanded plant will help cater for growing demand for delivery devices, particularly for systems used to administer treatments for diabetes and monitor glucose levels.

The firm predicted it will hire 100 employees over the next five years.

West also confirmed it has renamed the contracting business that operates the Mulhuddart facility - the Tech Group—explaining that the division will now be called “West.”

The expansion is one of two investments West is making in Ireland. In 2014 the delivery device firm announced it would build a manufacturing facility in Waterford, Ireland.

The plant will make a range of product, including packaging components for insulin injector cartridges, and is expected to bring another 150 jobs to the area.

Karen Flynn, Senior Vice President and Chief Commercial Officer at West said: “We are excited about the growth and expansion we are experiencing in both our contract manufacturing business in Dublin as well as our proprietary products business in Waterford, both of which will support increasing demand from our global customer base​.”  

The Waterford plant is expected to begin full commercial operations in 2018.

Related topics Drug Delivery Delivery technologies

Related news

Related products

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us


View more